ReviewCureus2023

Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management.

Aroob Fatima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.